Partial Agonist Buprenorphine — FRCA Primary MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Buprenorphine
Buprenorphine is a partial agonist at the mu-opioid receptor and an antagonist at the kappa-opioid receptor. Compared with a full agonist, it has lower intrinsic efficacy at the mu receptor, although its slowly reversible receptor binding allows it to displace other opioids. Consequently, giving it while a full agonist is still active can reduce net receptor activation and precipitate withdrawal in an opioid-dependent patient. Opioid agonist ceiling effects, including a ceiling in respiratory depression in clinical pharmacology studies, do not eliminate the risk of severe or fatal respiratory depression. Naloxone is an opioid antagonist, whereas methadone, morphine and fentanyl are full mu-opioid agonists.
Reference: Camurus AB. Buvidal 64 mg prolonged-release solution for injection, Summary of Product Characteristics, sections 4.4 and 5.1. Updated 29 June 2026. https://www.medicines.org.uk/emc/product/9706/smpc